key: cord-0701397-8ci61pr7
authors: Immergluck, Katherine; Gonzalez, Mark D.; Frediani, Jennifer K.; Levy, Joshua M.; Figueroa, Janet; Wood, Anna; Rogers, Beverly B.; O’Neal, Jared; Elias-Marcellin, Roger; Suessmith, Allie; Sullivan, Julie; Schinazi, Raymond F.; Babiker, Ahmed; Piantadosi, Anne; Vos, Miriam B.; Martin, Greg S.; Lam, Wilbur A.; Waggoner, Jesse J.
title: Correlation of SARS-CoV-2 Subgenomic RNA with Antigen Detection in Nasal Midturbinate Swab Specimens
date: 2021-11-03
journal: Emerg Infect Dis
DOI: 10.3201/eid2711.211135
sha: 8ba42f2b741eaef745e4e74aa3e2014441621f65
doc_id: 701397
cord_uid: 8ci61pr7

Among symptomatic outpatients, subgenomic RNA of severe acute respiratory syndrome coronavirus 2 in nasal midturbinate swab specimens was concordant with antigen detection but remained detectable in 13 (82.1%) of 16 nasopharyngeal swab specimens from antigen-negative persons. Subgenomic RNA in midturbinate swab specimens might be useful for routine diagnostics to identify active virus replication.

Among symptomatic outpatients, subgenomic RNA of severe acute respiratory syndrome coronavirus 2 in nasal midturbinate swab specimens was concordant with antigen detection but remained detectable in 13 (82.1%) of 16 nasopharyngeal swab specimens from antigennegative persons. Subgenomic RNA in midturbinate swab specimens might be useful for routine diagnostics to identify active virus replication.

We performed the sgRNA assay in 20-μL reactions using the Luna Probe One-Step RT-qPCR Kit (New England Biolabs, https://www.neb.com) with 500 nmol/L of each primer, 250 nmol/L of probe, and 5 μL of eluate by using the following conditions: 55°C for 15 min, 95°C for 2 min, and 45 cycles of 95°C for 15 s and 60°C for 60 s. We detected total SARS-CoV-2 RNA by using a duplex N2-RNase P rRT-PCR performed as described (12) . We obtained an anterior nares swab specimen for nucleocapsid antigen detection with the Abbott BinaxNOW COVID-19 Ag Card (swabs supplied with the BinaxNOW kit; Abbott Laboratories, https://www.abbott.com) performed per the package insert.

The first 73 participants had a midturbinate swab specimen available for molecular testing (evaluation group) and have been described (13). The subsequent 54 participants had dedicated midturbinate (n = 15) or residual nasopharyngeal (n = 39) swab specimens for molecular testing and available antigen test results (antigen testing group) (Appendix Figure 1 , https://wwwnc.cdc.gov/EID/ article/27/11/21-1135-App1.pdf).

We estimated nucleocapsid sgRNA as a percentage of total RNA by calculating copies per microliter of sgRNA and total RNA for each sample based on a standard curve for each target and then calculating the percentage of sgRNA. We used unpaired t-tests to compare continuous variables and the Fisher exact test for testing categorical variables. We performed simple linear regression to compare cycle threshold (C t ) values for sgRNA and total RNA. We conducted The evaluation group included midturbinate swab specimens from 36 adults and 37 children. All samples (73/73) were positive for SARS-CoV-2 by rRT-PCR. Samples with detectable sgRNA (62/73, 84.9%) had significantly lower C t values, indicative of higher viral loads, than samples without detectable sgRNA (mean C t 25.1, SD 5.5, vs. mean C t 35.5, SD 2.6; p<0.0001) (Figure 1, panel A) . sgRNA was detectable in all samples (49/49) that had N2 C t values <30 compared with 13 (54.2%) of 24 samples that had C t values >30 (p<0.0001). Although sgRNA rRT-PCR amplification efficiency was slightly lower than that for the N2 assay, there was a strong linear correlation between sgRNA and N2 C t values ( Figure 1 , panel B), and the assay provided linear sgRNA detection across the range of N2 C t values observed in this study (Appendix Figure 2 ). sgRNA C t values were a mean of 4.8 (SD 1.8) cycles higher than corresponding N2 C t values, and nucleocapsid gene sgRNA accounted for a mean of 1.4% (SD 1.1%) of SARS-CoV-2 RNA. Samples from children had higher viral loads than samples from adults, although the relative amount of sgRNA did not differ (Appendix Figure 3) .

We complied characteristics of participants in the antigen-testing group who had midturbinate (n = 15) swab specimens (Table 1 ) and nasopharyngeal (n = 39) swab specimens ( Table 2 ). All midturbinate swab specimens from participants who had detectable antigen (n = 8) were also positive for sgRNA, whereas 0/4 samples from antigen-negative persons were positive (κ 1.0). Samples that had detectable sgRNA had significantly lower C t values (mean 25.8, SD 2.7) than samples that did not have detectable sgRNA (mean 36.3, SD 1.8; p = 0.002) ( Figure 2) .

All (20/20) nasopharyngeal swab specimens from antigen-positive participants were positive for sgRNA. N2 C t values were significantly lower among antigen-positive participants (mean 18.2, SD 5.0) than antigen-negative participants (mean 27.8, SD 4.5; p<0.0001) (Figure 2 ). sgRNA was detectable in 13 (81.2%) of 16 nasopharyngeal swab specimens from antigen-negative persons. Days after symptom onset (when the sample was collected) did not differ significantly between antigen-positive and sgRNApositive/antigen-negative participants (mean 3.4, SD 1.9 days, vs. mean 3.8, SD 2.4 days; p = 0.6). Nucleocapsid gene sgRNA accounted for a smaller percentage of total SARS-CoV-2 RNA in antigennegative participants (mean 0.6%, SD 0.4%) vs. antigen-positive participants (mean 1.0%, SD 0.5%; p = 0.012) (Appendix Figure 4) . Compared with midturbinate swab specimens, nasopharyngeal swab specimens had lower C t values for RNase P (Appendix Figure 5 ).

SARS-CoV-2 sgRNA was detected in all samples from antigen-positive participants (28/28 total), consistent with identification of active viral replication and potential shedding (4, 5, 8) . However, among antigennegative participants, sgRNA detection varied between SARS-CoV-2 RNA-positive midturbinate (0/4) and nasopharyngeal (13/16) swab specimens. Although nasopharyngeal swab specimens are expected to have higher viral loads (14) , this difference did not appear to be the sole explanation. sgRNA represented a smaller proportion of total SARS-CoV-2 RNA in discordant nasopharyngeal swab specimens, and overall, nasopharyngeal swab specimens had higher amounts of human cellular material (lower RNase P C t values) than midturbinate swab specimens. Therefore, discordant sgRNA and antigen results in nasopharyngeal swab specimens probably resulted from persistent detection of waning SARS-CoV-2 infections with low levels of detectable sgRNA, which is only found in infected cells but insufficient viral replication to yield detectable nucleocapsid antigen in the anterior nares. Nucleocapsid antigen was detected by using the widely available BinaxNOW COVID-19 Ag Card. This card demonstrates similar performance to other rapid antigen tests, which commonly detect nucleocapsid protein, and maintains analytical sensitivity against SARS-CoV-2 variants (7). Therefore, it provided a useful and relevant comparator for sgRNA detection.

Limitations of our study include a relatively small number of midturbinate swab specimens tested in the antigen-testing group, which was affected by the need for multiple swab specimens at a single time point. The race/ethnicity makeup of groups that had midturbinate and nasopharyngeal swab specimens differed (Tables 1, 2) , although this limitation is not expected to have affected our findings (15) .

In conclusion, sgRNA detection in midturbinate swab specimens correlates with nucleocapsid antigen and could be implemented as a molecular test to evaluate infectivity. Given the strong correlation between sgRNA, nucleocapsid antigen, and total SARS-CoV-2 RNA, these data also support use of antigen testing or establishment of rRT-PCR C t values as markers of active replication. F rom the Greek proto-(fi rst) + thēkē (sheath), Prototheca is a genus of variably shaped spherical cells of achloric algae in the family Chlorellaceae. Wilhelm Krüger, a German expert in plant physiology and sugar production, reported Prototheca microorganisms in 1894, shortly after spending 7 years in Java studying sugarcane. He isolated Prototheca species from the sap of 3 tree species. Krüger named these organisms as P. moriformis and P. zopfi i, the second name as a tribute to Friedrich Wilhelm Zopf, a renowned botanist, mycologist, and lichenologist.

Protothecosis affects humans and wild and domestic animals, primarily causing mastitis in cows. Human protothecosis was reported in 1964 from a skin lesion in a farmer from Sierra Leone. There are increasing reports of infections in immunocompromised patients. Debates regarding Prototheca taxonomy persist. 

Centers for Disease Control and Prevention. Healthcare workers: information on COVID-19. 2021

SARS-CoV-2 total and subgenomic RNA viral load in hospitalized patients

Strand-specific reverse transcription PCR for detection of replicating SARS-CoV-2

SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild coronavirus disease

Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Rethinking COVID-19 test sensitivity: a strategy for containment

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration

Inference of active viral replication SARS-CoV-2 Subgenomic RNA and Antigen Detection in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

Virological assessment of hospitalized patients with COVID-2019

Comparison of subgenomic and total RNA in SARS-CoV-2 challenged rhesus macaques

Real-time RT-PCR panel for detection 2019-novel coronavirus, instructions for use

Triplex real-time RT-PCR for severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis

Comparing nasopharyngeal and midturbinate nasal swab testing for the identifi cation of severe acute respiratory syndrome coronavirus 2

Comparison of upper respiratory viral load distributions in asymptomatic and symptomatic children diagnosed with SARS-CoV-2 infection in pediatric hospital testing programs

Address for correspondence: Jesse J. Waggoner, Division of Infectious Diseases

A case of human protothecosis

Dorland's illustrated medical dictionary

Emergence of fungal-like organisms: Prototheca

Brief characteristics of some lower organisms in the sap fl ow of deciduous trees

We thank the staff of the Atlanta Center for Microsystems Engineered Point-of-Care Technologies for their contributions and efforts, and study participants and family members for providing samples and clinical information.This study was supported by the National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (grants U54 EB027690 02S1 and UL1 TR002378).